SPICYIP TIDBITS


1. BRAND SENSEX ENTERS THE TRADEMARK RING
Asia’s oldest bourse — the Bombay Stock Exchange — has sought trademark protection on the brand, along with 24 other trademarks, and the application is currently pending. Confirming this, the BSE spokesperson said all the trademarks will be registered in name of Bombay Stock Exchange shortly.

2. ONE OF STYLES RIPPED OFF
The who’s who of the Indian fashion industry is once again accusing the remaining who’s who of the fashion industry of copying their designs. Of course nobody knows the line between inspiration and blatant copying.

3. TRADEMARK BREACH: US SOFTWARE CO PLANS ACTION
The Nasdaq listed Compuware Corp. which makes business software and offers IT services and has been operating in India since 2002, recently discovered that an Indian software company has been carrying out business under the Compuware name. The Company is planning legal action for trademark infringement.

4. AN INTEL APPROACH TO PHARMA INNOVATION
Andy Grove, Time Magazine’s Man of the Year a decade ago and one of the founders of computer giant Intel is furious with the pace of innovation. He’s slammed the current system of pharma innovation as too slow and inefficient. Especially when compared with the computer industry whose pace of innovation far outpaces that of the pharma industry.

5. PHARMA PATENTS
a) The Federal Patent Court in Munich, Germany, has revoked Pfizer’s patent covering Lipitor’s active ingredient atorvastatin calcium. Generic manufacturers Ranbaxy Laboratories and Basics GmbH had challenged the patent.
b) the US District Court for the District of Delaware has rejected Dr Reddy’s Laboratories challenges to the validity and enforceability of Bayer’s patents over Avelox (moxifloxacin HCL), a fluroquinolone antibiotic for the treatment of respiratory tract and other infections.
c) Ranbaxy resolves patent dispute over Flomax.

6. INDIAN PHARMA INDUSTRY WELL POISED FOR GROWTH
The Indian pharmaceutical industry is well positioned for sustainable growth and expansion and is expected to grow at a cumulative annual growth rate (CAGR) of 16 per cent over 2007-11 according to a KPMG-Confederation of Indian Industry (CII) study entitled `Indian Pharma Inc. – A continuing success story.’
In the product patent regime, many Indian pharma companies have embarked on R&D activities to achieve a sustainable long term advantage. These are now adopting innovative funding models to advance their R&D activities. R&D investment today account for 7-9 per cnet of sales for leading pharma companies.

7. HOLLYWOOD ADVICES BOLLYWOOD IN PIRACY FIGHT
Big brother Hollywood is teaching its country cousin how to fight the ubiquitous street vendor who’s sells you DVDs for almost nothing. The MPAA President in a seminar at Delhi reeled out the usual stunning statistics on how piracy is hurting the film industry and how India needs to have stronger enforcement of copyright laws.

8. APPLE DRM PATENT VIOLATION
The 11-page complaint, filed in the patent litigation-friendly district of Tyler, Texas, charges APPLE with violating U.S. patent #6389541 for “Regulating Access to Digital Content,” which was issued to Digital Reg of Texas, LLC in May of 2002.

Prashant Reddy

Prashant Reddy

T. Prashant Reddy graduated from the National Law School of India University, Bangalore, with a B.A.LLB (Hons.) degree in 2008. He later graduated with a LLM degree (Law, Science & Technology) from the Stanford Law School in 2013. Prashant has worked with law firms in Delhi and in academia in India and Singapore. He is also co-author of the book Create, Copy, Disrupt: India's Intellectual Property Dilemmas (OUP).

Leave a Reply

Your email address will not be published.